HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Approves Switch Of Higher Dose Calcium And Vitamin D Combination

Executive Summary

The MHRA has approved the switch of Consilient Health's Calci-D, which will offer UK consumers the highest dose of vitamin D3 available in combination with calcium as an OTC medicine.

You may also be interested in...



UK MHRA Approves Sale Of Reckitt’s Nuromol Outside Pharmacy

Reckitt's Nuromol is the first combination of paracetamol and ibuprofen approved for sale in the UK outside of pharmacy. The company has also been granted one year of exclusivity for the data used to secure the reclassification.

HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 

UK Needs Higher Daily Vitamin D Supplement Doses To Achieve Immunity Effects

Current UK government guidelines on vitamin D supplementation (400IU or 10mcg vitamin D a day) are too low to achieve immunity boosting effects, says UK expert and University of Birmingham scientist Martin Hewison. 

Topics

UsernamePublicRestriction

Register

RS151830

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel